- Price
- $2.09
- Day
- -2.34%
- Mkt Cap
- $133.10M
- 52W Range
- $0.41 – $3.90
- Volume
- 199.5K
- Beta
- -0.01
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
TAMPA, Fla., July 22, 2026 /PRNewswire/ -- TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA" or the "Company"), a Phase 3 immuno-oncology company developing novel therapeutics to overcome resistance to cancer immunotherapy, today announced that James A.
Read full article